141 related articles for article (PubMed ID: 26744876)
21. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
[TBL] [Abstract][Full Text] [Related]
22. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
23. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
[TBL] [Abstract][Full Text] [Related]
24. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
[TBL] [Abstract][Full Text] [Related]
25. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.
Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W
Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710
[TBL] [Abstract][Full Text] [Related]
26. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
Qian J; Lin J; Qian W; Ma JC; Qian SX; Li Y; Yang J; Li JY; Wang CZ; Chai HY; Chen XX; Deng ZQ
Leuk Res; 2013 Jul; 37(7):765-8. PubMed ID: 23582927
[TBL] [Abstract][Full Text] [Related]
28. miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.
Cheng YC; Fan Z; Liang C; Peng CJ; Li Y; Wang LN; Luo JS; Zhang XL; Liu Y; Zhang LD
Technol Cancer Res Treat; 2024; 23():15330338241248576. PubMed ID: 38693824
[No Abstract] [Full Text] [Related]
29. Lower Serum miR-145 Predicts Poor Prognosis in Patients with Acute Myeloid Leukemia.
Shi Q; Xing G; Qi M; Xing Y
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538049
[TBL] [Abstract][Full Text] [Related]
30. Serum miR-133 as a novel biomarker for predicting treatment response and survival in acute myeloid leukemia.
Zheng ZZ; Ma YP; Wu RH; Rong G; Li C; Li GX; Ren FG; Xu LJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):777-783. PubMed ID: 32016982
[TBL] [Abstract][Full Text] [Related]
31. High receptor tyrosine kinase (FLT3, KIT) transcript versus anti-apoptotic (BCL2) transcript ratio independently predicts inferior outcome in pediatric acute myeloid leukemia.
Sharawat SK; Bakhshi R; Vishnubhatla S; Bakhshi S
Blood Cells Mol Dis; 2015 Jan; 54(1):56-64. PubMed ID: 25216797
[TBL] [Abstract][Full Text] [Related]
32. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ
Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
Hong Z; Zhang R; Qi H
Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
[TBL] [Abstract][Full Text] [Related]
34. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
35. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
[TBL] [Abstract][Full Text] [Related]
36. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
Huang Y; Zou Y; Lin L; Ma X; Chen H
Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
[TBL] [Abstract][Full Text] [Related]
37. MiR-100 regulates cell viability and apoptosis by targeting ATM in pediatric acute myeloid leukemia.
Sun Y; Wang H; Luo C
Biochem Biophys Res Commun; 2020 Feb; 522(4):855-861. PubMed ID: 31801665
[TBL] [Abstract][Full Text] [Related]
38. [Correlation of MiR-34a/b/c Expression with Treatment Response and Prognosis of Elderly Patients with Acute Myeloid Leukemia].
Li H; Bao HX; Qin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):476-483. PubMed ID: 32319382
[TBL] [Abstract][Full Text] [Related]
39. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia.
Kondo M; Horibe K; Takahashi Y; Matsumoto K; Fukuda M; Inaba J; Kato K; Kojima S; Matsuyama T
Med Pediatr Oncol; 1999 Dec; 33(6):525-9. PubMed ID: 10573574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
